Summary
In 1H FY12/2026, Tamron grew revenue despite lower OEM sales in the Photography-Related Business. Double-digit growth in the Surveillance & FA-Related Business and the Mobility & Healthcare, and Other Business more than offset the OEM decline. Operating income nonetheless fell, reflecting lower revenue in the high-margin Photography-Related Business and higher SG&A. The company kept its full-year profit plan unchanged and expects double-digit revenue and profit growth in 2H.
The key question for 3Q, the first quarter of 2H, is whether standalone revenue and operating income exceed prior-year levels. We will also look for a recovery in the Photography-Related Business, supported by new in-house brand products and a bottoming-out in OEM. Continued growth in the two industrial businesses is the other area to watch. A further checkpoint is how far gross profit margin recovers as procurement and logistics costs rise on the Middle East situation. Finally, the profit impact of the revised FX assumptions, now set at a weaker yen, will help gauge the credibility of the full-year plan.
Key Points for Next Quarter
| Key Points & Focus | Implications |
|---|---|
2H Turnaround3Q standalone revenue and operating income YoY | By our estimate, the 2H plan implies revenue of JPY 49,718M (+14.7%) and operating income of JPY 10,810M (+45.4%). The first test of plan credibility is whether 3Q beats prior-year 3Q standalone revenue of JPY 21,389M and operating income of JPY 4,183M. |
Photography-Related BusinessSales trends for OEM models and contribution from new in-house brand products | 1H revenue was JPY 27,534M (-8.2%) and segment profit was JPY 5,943M (-29.3%). The company expects revenue and profit growth in every segment for the full year, which requires a reversal in 2H. |
Industrial BusinessesSustained revenue growth in Surveillance & FA-Related Business and Mobility & Healthcare, and Other Business | 1H revenue grew +29.0% and +39.6%, respectively. Higher expected sales in the latter drove the +JPY 2,000M upward revision to full-year revenue. We will check whether both businesses sustain high growth on a 9M cumulative basis. |
ProfitabilityGross profit margin and SG&A trends | 2Q standalone gross profit margin was 40.0%, down from 44.9% a year earlier (our estimate). The extent of recovery amid rising procurement and logistics costs will determine whether the unchanged profit plan holds. |
FX ImpactRevised FX assumptions and impact on revenue and profit | Assumptions from 3Q onward were revised to a weaker yen: USD 1 = JPY 160 and EUR 1 = JPY 180. FX lifted 1H revenue by JPY 2.48B and operating income by JPY 1.03B. For 2H, each JPY 1 of yen appreciation reduces revenue by JPY 170M (USD) and JPY 40M (EUR), and operating income by JPY 40M (USD) and JPY 30M (EUR). We will assess how far a sustained weak yen raises the likelihood of hitting the full-year profit plan. |
Key Issues from Previous Results (FY12/2026 2Q Results)
1H revenue was JPY 43,281M (+3.8%) and operating income was JPY 7,689M (-16.5%). The company described progress as "broadly in line with plan." It raised the full-year revenue plan from JPY 91,000M to JPY 93,000M. Operating income and recurring profit plans were both kept at JPY 18,500M. 3Q will show whether a narrower revenue decline in Photography and growth in the two industrial businesses can drive a return to profit growth in 2H.
1. Shift to Double-Digit Revenue and Profit Growth in 2H, Starting with 3Q Standalone Results
- Previous Period: Standalone revenue swung from -5.0% in 1Q to +11.4% in 2Q. Operating income kept declining, falling -18.7% in 1Q and -14.5% in 2Q (our estimate).
- To Verify This Quarter: The company expects double-digit revenue and profit growth in 2H. We will check whether profit turns positive in 3Q, the first quarter of 2H.
- Key Metrics: Compare 3Q standalone operating income with the prior-year JPY 4,183M. Also track 9M cumulative recurring profit progress against the full-year plan of JPY 18,500M (prior-year 9M recurring profit: JPY 13,470M).
2. OEM Bottoming-Out and New In-House Brand Product Effect in the Photography-Related Business
- Previous Period: Revenue was JPY 27,534M (-8.2%) and segment profit was JPY 5,943M (-29.3%). Weak sales of certain OEM models persisted from 2H of the prior year.
- Previous Period: In-house brand revenue grew by double digits in the US, Europe and India, and Japan was also strong. China declined on excess market inventory.
- To Verify This Quarter: The OEM slowdown began in 2H of the prior year, so YoY comparisons may ease from 3Q. The focus is how far the revenue decline narrows.
- To Verify This Quarter: The company plans to launch 10+ new products in 2026. We will look at the contribution from models such as the A078, launched in March, and progress on inventory adjustment in China.
- Key Metrics: Track 9M cumulative segment revenue and profit YoY (1H: -8.2% and -29.3%). Also monitor Photography revenue in Asia (1H: JPY 13,141M vs. JPY 18,148M a year earlier).
- Key Metrics: For full-year revenue and profit growth, as the company expects, the YoY increase in 2H must exceed the 1H shortfall (revenue -JPY 2,448M, profit -JPY 2,459M) (our estimate).
3. Sustained Growth in the Two Industrial Businesses
- Previous Period: Surveillance & FA-Related Business revenue was JPY 7,711M (+29.0%) and segment profit was JPY 1,026M (+10.5%).
- Previous Period: Mobility & Healthcare, and Other Business revenue was JPY 8,035M (+39.6%) and segment profit was JPY 1,987M (+48.0%).
- To Verify This Quarter: Higher sales in Mobility & Healthcare, and Other Business drove the full-year revenue upgrade. We will check whether growth continues in lenses for ADAS automotive cameras and medical lenses.
- To Verify This Quarter: Surveillance & FA-Related Business segment margin was 13.3%, below 15.5% a year earlier (our estimate). We want to understand why profit growth lags revenue growth.
- Key Metrics: Track 9M cumulative revenue and segment margin YoY for both businesses. Also monitor their combined share of revenue (1H: 36.4% vs. 28.1% a year earlier, our estimate).
4. Gross Profit Margin and Progress on Cost Absorption
- Previous Period: 1H gross profit margin was 41.9%, down from 45.3% a year earlier. 2Q standalone was 40.0% (prior year: 44.9%) (our estimate).
- Previous Period: SG&A was JPY 10,441M (+7.5%). Salaries and bonuses were JPY 2,694M (+11.8%), and R&D expenses were JPY 3,693M (+6.1%).
- To Verify This Quarter: The company kept its profit plan unchanged after factoring in higher procurement and logistics costs from the Middle East situation. We will check how much is being absorbed through cost reductions and productivity gains.
- To Verify This Quarter: We want management to clarify whether the margin decline reflects product mix or cost factors. We will also review the breakdown of extraordinary items and income taxes.
- Key Metrics: Track 3Q standalone gross profit margin (prior year: 43.9%; 2Q standalone: 40.0%) and 3Q standalone SG&A (prior year: JPY 5,210M). Also monitor inventories (end-1H: JPY 17,725M vs. JPY 16,768M at prior fiscal year-end).
5. Revised FX Assumptions and Non-Operating Items
- Previous Period: 1H average rates were about JPY 10 weaker against the USD and about JPY 22 weaker against the EUR YoY. FX impact was JPY 2.48B on revenue and JPY 1.03B on operating income.
- To Verify This Quarter: Assumptions from 3Q onward were revised to USD 1 = JPY 160 (from JPY 148) and EUR 1 = JPY 180 (from JPY 175). The revenue plan was raised by JPY 2,000M, but the profit plan was left unchanged.
- To Verify This Quarter: We will examine how the revenue boost from a weaker yen nets against rising procurement and logistics costs.
- Key Metrics: Track 9M cumulative FX impact and progress against the full-year plan.
Key Timely Disclosures During the Period
- 2026/10/14Launch of the "16-50mm F2.8 A (Model B091)" large-aperture standard zoom lens for APS-C in four mounts - Simultaneous release for Sony E, Nikon Z, FUJIFILM X and Canon RF broadens mount coverage for the in-house brand. The announcement came after the 3Q period end, so any contribution will appear from 4Q results onward.
- 2026/09/07Announced plans to enter the laser welding and processing solutions field - The company plans to launch a "beam profiler" and a "laser processing head" during 2027. This medium- to long-term initiative expands the business from optical components into optical systems and has no impact on 3Q earnings.
Previous Quarter Results (FY12/2026 2Q Actual)
Tamron is an optical manufacturer centered on interchangeable lenses. It operates three segments: the Photography-Related Business (in-house brand and OEM), the Surveillance & FA-Related Business, and the Mobility & Healthcare, and Other Business. In 1H (interim cumulative), Photography revenue fell on weak OEM sales. Consolidated revenue still grew, supported by double-digit growth in the two industrial businesses and a weaker yen. Profit declined on lower revenue in the high-margin Photography-Related Business and higher personnel and R&D costs. The company described results as "broadly in line with plan" and raised its full-year revenue plan to JPY 93,000M.
| Item | Amount | YoY | vs. Company Plan | Notes |
|---|---|---|---|---|
| Revenue | JPY 43,281M | +3.8% | - | Double-digit growth in the two industrial businesses and a weaker yen offset the Photography revenue decline |
| Operating Income | JPY 7,689M | -16.5% | - | Operating Income Margin of 17.8% (prior year: 22.1%, our estimate), pressured by lower Photography revenue and higher SG&A |
| Recurring Profit | JPY 7,741M | -16.5% | - | Includes FX loss of JPY 421M |
| Interim Net Income Attributable to Owners of Parent Company | JPY 6,197M | -9.9% | - | Absence of the prior-year JPY 414M loss on sale of investment securities |
| EPS | JPY 38.42 | -9.6% | - | - |
Guidance Achievement Rate vs. Full-Year Plan (Recurring Profit Basis): 41.8% (prior-year period: 55.5%)
The prior-year ratio is measured against FY12/2025 full-year actual recurring profit of JPY 16,699M, not the full-year plan (our estimate).
ENVALITH, INC. ("ENVALITH") provides exclusive research coverage services to domestic and international institutional investors, as well as domestic individual investors, with the objective of contributing to the development of global and Japanese capital markets by providing information necessary for considering investments in Japanese listed companies.
- Purpose and Disclaimer Regarding Investment Decisions
This report has been prepared solely for informational purposes and does not constitute a solicitation to acquire, sell, or hold securities or any other financial products. Furthermore, this report does not constitute specific investment, financial, or tax advice. Any opinions, judgments, or recommendations contained herein are not intended to induce investment activities. Please be advised that all investment decisions must be made based on the investor's own responsibility and judgment, and ENVALITH and subject company shall not be involved in any such investment decisions.
- Information Sources, Accuracy, and Disclaimer of Warranty
This report has been prepared based on a formal request from the subject company, utilizing information provided by and interviews conducted with said company. By using this report, you are deemed to have agreed to the following: 1. Information Sources: This report is prepared on the assumption that the publicly available information and information disclosed by the subject company and provided during interviews is true and reliable. ENVALITH has not independently verified or validated the veracity of such information. 2. Accuracy: The interpretations, analyses, and hypotheses or conclusions based thereon contained in this report are independently derived by ENVALITH using its own perspectives and analytical methods based on the information mentioned in the preceding paragraph. 3. Disclaimer of Warranty: In the event that there are errors or omissions in the information disclosed by the subject company, ENVALITH and subject company shall not be held liable for any inaccuracies in this report resulting therefrom. ENVALITH and subject company make no warranties, whether express or implied, regarding the accuracy, safety, validity, completeness, or any other aspect of this report, nor regarding the past or future performance of the subject company.
- Limitation of Liability
ENVALITH and subject company shall not be liable for any costs, damages, or losses (including direct, indirect, incidental, consequential, or punitive damages) arising from the use of this report or the information obtained therefrom. Users of this report acknowledge and agree that such use is at their own risk.
- Potential Conflicts of Interest
ENVALITH may have, or may have in the future, business relationships with the subject company. Accordingly, investors should be aware that conflicts of interest may exist that could affect the objectivity of this report.
- No Obligation to Change or Update Content
The contents and opinions in this report, as well as the information upon which it is based, are current as of the date of preparation and are subject to change without notice. Please be advised that ENVALITH is under no obligation to update the contents of this report, and investors must verify the timeliness of the information on their own.
- Governing Language
This report is prepared in Japanese, English, and Chinese. In the event of any discrepancy or difference in interpretation between the language versions, the Japanese version shall be treated as the original and shall prevail.
- Copyright
All rights (including copyrights) relating to this report belong to ENVALITH. Any reproduction, redistribution, or other use of all or part of this report without the prior written permission of ENVALITH is strictly prohibited.
- Use for Other Investment Products
Except where ENVALITH has provided prior written approval, the use of this report and the trademarks or trade names of ENVALITH or the subject company in connection with the information distribution, transaction, sales promotion, or advertising of any investment products (including derivatives, structured products, investment trusts, or investment assets whose price, return, or performance is based on or linked to this report) is strictly prohibited.